The proposed negative impact of IFITM1 on TTR and OS in esophageal adenocarcinoma has to be interpreted with caution since it was only demonstrated in the adjusted Cox regression analysis. This evidence concerns the gene IFITM1 and esophageal adenocarcinoma.